NYSE:MDT - Medtronic Stock Price, Price Target & More

$80.22 +0.32 (+0.40 %)
(As of 04/23/2018 01:06 PM ET)
Previous Close$79.90
Today's Range$79.96 - $80.45
52-Week Range$76.41 - $89.72
Volume1.02 million shs
Average Volume5.37 million shs
Market Capitalization$108.29 billion
P/E Ratio17.43
Dividend Yield2.30%
Beta0.94

About Medtronic (NYSE:MDT)

Medtronic logoMedtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company's Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions. The company's Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company's Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:MDT
CUSIP58505510
Phone353-1438-1700

Debt

Debt-to-Equity Ratio0.51%
Current Ratio2.43%
Quick Ratio2.09%

Price-To-Earnings

Trailing P/E Ratio17.43
Forward P/E Ratio16.92
P/E Growth2.38

Sales & Book Value

Annual Sales$29.71 billion
Price / Sales3.66
Cash Flow$6.8389 per share
Price / Cash11.73
Book Value$36.83 per share
Price / Book2.18

Profitability

EPS (Most Recent Fiscal Year)$4.60
Net Income$4.03 billion
Net Margins9.44%
Return on Equity12.65%
Return on Assets6.58%

Miscellaneous

Employees91,000
Outstanding Shares1,355,370,000

How to Become a New Pot Stock Millionaire

Medtronic (NYSE:MDT) Frequently Asked Questions

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Friday, March 9th. Stockholders of record on Friday, March 23rd will be given a dividend of $0.46 per share on Friday, April 13th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date is Thursday, March 22nd. View Medtronic's Dividend History.

How will Medtronic's stock buyback program work?

Medtronic announced that its board has approved a stock repurchase plan on Thursday, October 5th 2017, which authorizes the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 49% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its shares are undervalued.

How were Medtronic's earnings last quarter?

Medtronic (NYSE:MDT) issued its quarterly earnings results on Tuesday, February, 20th. The medical technology company reported $1.17 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.16 by $0.01. The medical technology company earned $7.37 billion during the quarter, compared to analyst estimates of $7.20 billion. Medtronic had a return on equity of 12.65% and a net margin of 9.44%. Medtronic's revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.12 earnings per share. View Medtronic's Earnings History.

When is Medtronic's next earnings date?

Medtronic is scheduled to release their next quarterly earnings announcement on Thursday, May, 24th 2018. View Earnings Estimates for Medtronic.

What price target have analysts set for MDT?

22 brokerages have issued 1-year price targets for Medtronic's stock. Their forecasts range from $80.00 to $99.00. On average, they anticipate Medtronic's share price to reach $91.2368 in the next twelve months. View Analyst Ratings for Medtronic.

What are Wall Street analysts saying about Medtronic stock?

Here are some recent quotes from research analysts about Medtronic stock:
  • 1. According to Zacks Investment Research, "Medtronic exited the fiscal second quarter on a mixed note. While the company demonstrated improved segmental performances at CER, escalating costs and expenses continue to weigh on the bottom line. Unfavorable currency translation also acted as a dampener. On the bright side, all major business groups contributed to solid top-line growth at CER, which highlighted sustainability across groups and regions, in addition to displaying successful integration and achievement of synergy targets. We are also encouraged by the solid growth trend in the United States as well as healthy global acceptance of its advanced therapies. The recent receipt of FDA approval and commercial launch of Azure pacemakers with BlueSync technology buoy optimism. Apart from product innovation, the company is focusing on geographical diversification of its businesses. The stabilizing trend in the global Cardiac Rhythm & Heart Failure (CRHF) market is another upside." (11/23/2017)
  • 2. Needham & Company LLC analysts commented, "On 11/8/17, MDT preannounced F2Q18 revenue of $7.050B (up 3% organic Y/Y) vs. consensus of $6.897M. The impact from Hurricane Maria was revised down to ~$60M from ~$250M, which equates to ~1% in quarterly revenue growth and ~$0.03 in non-GAAP EPS. MDT did not update its FY18 revenue or EPS guidance in the press release but did reaffirm F2Q18 non-GAAP EPS growth of flat to slightly up, excluding the ~$0.03 headwind. MDT is scheduled to report full F2Q18 results on 11/21/17 and we intend to wait until then to update our model." (11/9/2017)

Who are some of Medtronic's key competitors?

Who are Medtronic's key executives?

Medtronic's management team includes the folowing people:
  • Mr. Omar S. Ishrak, Chairman and Chief Exec. Officer (Age 62)
  • Ms. Karen L. Parkhill, Exec. VP & CFO (Age 53)
  • Mr. Michael J. Coyle, Exec. VP and Group Pres of Cardiac & Vascular Group (Age 56)
  • Mr. Robert J. W. ten Hoedt, Exec. VP and Group Pres, Europe, Middle East & Africa (Age 57)
  • Mr. Mark Ploof, Sr. VP of Global Operations & Bus. Services

Has Medtronic been receiving favorable news coverage?

News stories about MDT stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medtronic earned a daily sentiment score of 0.09 on Accern's scale. They also assigned headlines about the medical technology company an impact score of 46.32 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $80.16.

How big of a company is Medtronic?

Medtronic has a market capitalization of $108.29 billion and generates $29.71 billion in revenue each year. The medical technology company earns $4.03 billion in net income (profit) each year or $4.60 on an earnings per share basis. Medtronic employs 91,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]


MarketBeat Community Rating for Medtronic (MDT)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  907 (Vote Outperform)
Underperform Votes:  580 (Vote Underperform)
Total Votes:  1,487
MarketBeat's community ratings are surveys of what our community members think about Medtronic and other stocks. Vote "Outperform" if you believe MDT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medtronic (NYSE:MDT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
22 Wall Street analysts have issued ratings and price targets for Medtronic in the last 12 months. Their average twelve-month price target is $91.2368, suggesting that the stock has a possible upside of 13.73%. The high price target for MDT is $99.00 and the low price target for MDT is $80.00. There are currently 6 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.732.732.652.57
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $91.2368$91.50$90.2368$88.35
Price Target Upside: 13.73% upside14.52% upside3.41% upside14.84% upside

Medtronic (NYSE:MDT) Consensus Price Target History

Price Target History for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/29/2018Morgan StanleyLower Price TargetEqual Weight -> Equal Weight$95.00 -> $90.00MediumView Rating Details
3/20/2018OppenheimerReiterated RatingBuyLowView Rating Details
2/22/2018CitigroupReiterated RatingBuy -> Buy$100.00 -> $93.00LowView Rating Details
2/14/2018Royal Bank of CanadaReiterated RatingOutperform$92.00MediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$92.50HighView Rating Details
1/2/2018Bank of AmericaUpgradeNeutral -> BuyHighView Rating Details
12/12/2017ArgusUpgradeHold -> Buy$81.27 -> $95.00LowView Rating Details
12/12/2017BMO Capital MarketsBoost Price TargetOutperform$94.00LowView Rating Details
11/23/2017Jefferies GroupReiterated RatingBuy$99.00N/AView Rating Details
11/22/2017Northland SecuritiesReiterated RatingHold$80.00N/AView Rating Details
11/22/2017Stifel NicolausBoost Price TargetHold$83.00 -> $85.00N/AView Rating Details
11/19/2017SunTrust BanksSet Price TargetBuy$92.00N/AView Rating Details
11/9/2017Needham & Company LLCReiterated RatingBuy$94.00N/AView Rating Details
11/3/2017CowenReiterated RatingBuy$95.00N/AView Rating Details
10/9/2017Leerink SwannReiterated RatingMarket Perform$88.00 -> $85.00N/AView Rating Details
10/9/2017Wells FargoDowngradeOutperform -> Market Perform$93.00 -> $83.00N/AView Rating Details
8/24/2017UBSReiterated RatingOverweightLowView Rating Details
8/23/2017BarclaysLower Price TargetOverweight$94.00 -> $92.00LowView Rating Details
7/31/2017Deutsche BankSet Price TargetBuy$96.00LowView Rating Details
7/6/2017William BlairReiterated RatingOutperformMediumView Rating Details
5/26/2017CIBCReiterated RatingBuyLowView Rating Details
5/16/2017Goldman SachsInitiated CoverageNeutral -> Neutral$87.00LowView Rating Details
3/20/2017BTIG ResearchReiterated RatingNeutralLowView Rating Details
2/22/2017WedbushReiterated RatingNeutral$85.00N/AView Rating Details
1/3/2017JPMorgan ChaseDowngradeOverweight -> Neutral$84.00 -> $79.00N/AView Rating Details
8/25/2016Credit Suisse GroupReiterated RatingOutperform$92.00N/AView Rating Details
6/15/2016Piper JaffrayReiterated RatingOverweight$93.00 -> $94.00N/AView Rating Details
6/8/2016GuggenheimInitiated CoverageNeutralN/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Medtronic (NYSE:MDT) Earnings History and Estimates Chart

Earnings by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) Earnings Estimates

2018 EPS Consensus Estimate: $4.71
2019 EPS Consensus Estimate: $5.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20186$1.07$1.15$1.10
Q2 20187$0.89$1.20$1.03
Q3 20187$1.15$1.24$1.18
Q4 20187$1.38$1.46$1.40
Q1 20194$1.12$1.22$1.18
Q2 20194$1.18$1.26$1.21
Q3 20194$1.29$1.32$1.30
Q4 20194$1.46$1.56$1.51

Medtronic (NYSE MDT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/24/2018$1.40N/AView Earnings Details
2/20/2018Q3 18$1.16$1.17$7.2012 billion$7.3690 billionViewListenView Earnings Details
11/21/2017Q2 18$0.99$1.07$7.0493 billion$7.05 billionViewN/AView Earnings Details
8/22/20177/31/2017$1.08$1.12$7.4441 billion$7.39 billionViewN/AView Earnings Details
5/25/2017Q4 17$1.31$1.33$7.8602 billion$7.9160 billionViewN/AView Earnings Details
2/21/20171/31/2017$1.11$1.12$7.2171 billion$7.2830 billionViewListenView Earnings Details
11/22/2016Q217$1.11$1.12$7.46 billion$7.35 billionViewListenView Earnings Details
8/25/2016Q117$1.01$1.03$7.1694 billion$7.20 billionViewListenView Earnings Details
5/31/2016Q416$1.26$1.27$7.49 billion$7.57 billionViewListenView Earnings Details
3/1/2016Q316$1.06$1.06$6.99 billion$6.93 billionViewListenView Earnings Details
12/3/2015Q216$1.00$1.03$7.0754 billion$7.0580 billionViewListenView Earnings Details
9/3/2015Q116$1.01$1.02$7.0291 billion$7.2740 billionViewListenView Earnings Details
6/2/2015Q415$1.11$1.16$7.1771 billion$7.30 billionViewListenView Earnings Details
2/17/2015Q3$0.97$1.01$4.25 million$4.32 millionViewListenView Earnings Details
11/18/2014Q2$0.96$0.96$4.37 million$4.40 millionViewListenView Earnings Details
8/19/2014Q115$0.92$0.93$4.25 billion$4.27 billionViewListenView Earnings Details
5/20/2014Q414$1.12$1.12$4.58 billion$4.60 billionViewListenView Earnings Details
2/18/2014Q314$0.91$0.91$4.15 billion$4.20 billionViewListenView Earnings Details
11/19/2013Q214$0.90$0.91$4.18 billion$4.20 billionViewListenView Earnings Details
8/20/2013Q1 2014$0.88$0.88$4.11 billion$4.10 billionViewListenView Earnings Details
5/21/2013Q4 2013$1.03$1.10$4.39 billion$4.50 billionViewListenView Earnings Details
2/19/2013Q3 2013$0.91$0.93$4.03 billion$4.03 billionViewListenView Earnings Details
11/20/20120.88$0.88$4.10 billionViewN/AView Earnings Details
8/21/2012$0.85$0.85ViewN/AView Earnings Details
5/22/2012$0.98$0.99ViewN/AView Earnings Details
2/21/2012$0.84$0.88ViewN/AView Earnings Details
11/22/2011$0.82$0.84ViewN/AView Earnings Details
8/23/2011$0.79$0.79ViewN/AView Earnings Details
5/24/2011$0.93$0.90ViewN/AView Earnings Details
2/22/2011$0.84$0.86ViewN/AView Earnings Details
11/23/2010Q2 2011$0.81$0.82ViewN/AView Earnings Details
8/24/2010Q1 2011$0.82$0.80ViewN/AView Earnings Details
5/25/2010Q4 2010$0.88$0.89ViewN/AView Earnings Details
2/23/2010Q3 2010$0.76$0.77ViewN/AView Earnings Details
11/24/2009Q2 2010$0.74$0.77ViewN/AView Earnings Details
8/25/2009Q1 2010$0.78$0.79ViewN/AView Earnings Details
5/19/2009Q4 2009$0.82$0.82ViewN/AView Earnings Details
2/17/2009Q3 2009$0.71$0.71ViewN/AView Earnings Details
11/18/2008Q2 2009$0.71$0.67ViewN/AView Earnings Details
8/19/2008Q1 2009$0.69$0.72ViewN/AView Earnings Details
5/20/2008Q4 2008$0.73$0.78ViewN/AView Earnings Details
2/19/2008Q3 2008$0.61$0.63ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Medtronic (NYSE:MDT) Dividend Information

Medtronic pays an annual dividend of $1.84 per share, with a dividend yield of 2.29%. MDT's most recent quarterly dividend payment was Friday, April 13. The company has grown its dividend for the last 40 consecutive years and is increasing its dividend by an average of 15.00% each year. Medtronic pays out 40.00% of its earnings out as a dividend.
Most Recent Dividend:4/13/2018
Annual Dividend:$1.84
Dividend Yield:2.29%
Dividend Growth:15.00% (3 Year Average)
Payout Ratio:40.00% (Trailing 12 Months of Earnings)
38.82% (Based on This Year's Estimates)
35.73% (Based on Next Year's Estimates)
Track Record:40 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/9/2018Quarterly$0.462.2%3/22/20183/23/20184/13/2018
12/8/2017Quarterly$0.4612/28/201712/29/20171/19/2018
8/28/2017Quarterly$0.462.31%9/28/20179/29/201710/20/2017
6/23/2017Quarterly$0.462.07%7/5/20177/7/20177/26/2017
3/10/2017Quarterly$0.432.08%3/22/20173/24/20174/13/2017
12/9/2016quarterly$0.432.33%12/21/201612/23/20161/13/2017
8/22/2016Quarterly$0.431.98%9/27/20169/29/201610/21/2016
6/24/2016quarterly$0.431.85%7/6/20167/8/20167/27/2016
2/22/2016quarterly$0.381.98%3/22/20163/24/20164/15/2016
12/11/2015quarterly$0.381.96%12/22/201512/24/20151/15/2016
8/21/2015quarterly$0.382.18%9/23/20159/25/201510/16/2015
6/19/2015quarterly$0.381.97%6/25/20156/29/20157/17/2015
2/20/2015quarterly$0.30501.55%3/26/20153/30/20154/17/2015
12/4/2014$0.305012/30/20141/2/20151/16/2015
12/5/2014quarterly$0.30501.63%12/30/20141/2/20151/6/2015
8/21/2014quarterly$0.30501.92%10/1/201410/3/201410/24/2014
6/16/2014quarterly$0.30501.98%7/1/20147/3/20147/25/2014
2/14/2014quarterly$0.281.97%4/2/20144/4/20144/25/2014
12/5/2013quarterly$0.281.93%12/31/20131/3/20141/24/2014
8/22/2013quarterly$0.282.12%10/2/201310/4/201310/25/2013
6/21/2013quarterly$0.282.13%7/2/20137/5/20137/26/2013
2/15/2013quarterly$0.262.21%4/3/20134/5/20134/26/2013
12/9/2012quarterly$0.262.44%12/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Medtronic (NYSE MDT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.31%
Institutional Ownership Percentage: 81.76%
Insider Trading History for Medtronic (NYSE:MDT)
Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE MDT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2018James T. LenehanDirectorSell1,306$83.56$109,129.36View SEC Filing  
3/5/2018Carol A SurfaceSVPSell24,479$78.18$1,913,768.22View SEC Filing  
1/9/2018Richard KuntzVPSell78,526$86.21$6,769,726.46149,761View SEC Filing  
1/5/2018Hooman HakamiEVPSell26,158$85.00$2,223,430.00View SEC Filing  
12/15/2017Bryan C HansonEVPSell16,000$82.82$1,325,120.0088,818View SEC Filing  
11/16/2017Bryan C. HansonEVPSell16,000$79.02$1,264,320.00View SEC Filing  
10/16/2017Bryan C HansonEVPSell16,000$78.03$1,248,480.00View SEC Filing  
9/15/2017Omar IshrakCEOSell140,407$81.63$11,461,423.41668,503View SEC Filing  
7/17/2017Bryan C. HansonEVPSell12,000$88.57$1,062,840.00View SEC Filing  
6/21/2017Richard H AndersonDirectorBuy5,600$88.90$497,840.0071,910View SEC Filing  
3/20/2017Hoedt Rob TenEVPSell50,757$81.58$4,140,756.0659,392View SEC Filing  
3/15/2017Omar IshrakCEOSell95,000$82.82$7,867,900.00645,616View SEC Filing  
3/2/2017Hooman HakamiEVPSell52,316$82.33$4,307,176.2873,800View SEC Filing  
12/13/2016Robert C. PozenDirectorBuy13,660$73.21$1,000,048.60View SEC Filing  
11/23/2016James T. LenehanDirectorBuy2,000$73.27$146,540.00View SEC Filing  
9/27/2016Richard KuntzVPSell17,141$86.70$1,486,124.70149,425View SEC Filing  
9/26/2016Richard KuntzVPSell25,199$86.67$2,183,997.33149,425View SEC Filing  
9/15/2016Kendall J. PowellDirectorSell7,907$85.45$675,653.15View SEC Filing  
9/15/2016Omar IshrakCEOSell61,925$84.93$5,259,290.25565,916View SEC Filing  
8/29/2016Bryan C HansonEVPSell15,000$87.00$1,305,000.00168,192View SEC Filing  
7/26/2016Bryan C HansonEVPSell15,000$87.00$1,305,000.00108,717View SEC Filing  
7/15/2016Geoffrey MarthaEVPSell3,766$88.26$332,387.16View SEC Filing  
7/13/2016Gary Lee EllisEVPSell35,495$88.64$3,146,276.80View SEC Filing  
7/13/2016Shirley A JacksonDirectorSell2,104$88.64$186,498.5634,503View SEC Filing  
7/6/2016Carol A. SurfaceSVPSell9,787$87.08$852,251.96View SEC Filing  
7/5/2016Bryan C. HansonEVPSell15,272$87.11$1,330,343.92View SEC Filing  
6/3/2016Richard KuntzVPSell49,905$82.60$4,122,153.00127,647View SEC Filing  
4/1/2016Richard KuntzVPSell4,000$75.22$300,880.00104,358View SEC Filing  
3/18/2016Shirley A JacksonDirectorSell1,238$75.60$93,592.8029,812View SEC Filing  
3/17/2016Omar IshrakCEOSell23,799$76.15$1,812,293.85601,838View SEC Filing  
3/4/2016Bryan C HansonEVPSell5,000$75.00$375,000.0096,806View SEC Filing  
2/5/2016Bryan C. HansonEVPSell5,000$76.14$380,700.00View SEC Filing  
1/8/2016Bryan C HansonEVPSell5,000$75.00$375,000.00106,514View SEC Filing  
12/4/2015Richard KuntzVPSell13,715$78.06$1,070,592.90108,086View SEC Filing  
9/15/2015Omar IshrakCEOSell20,000$69.43$1,388,600.00526,824View SEC Filing  
7/14/2015Carol A SurfaceSVPSell13,722$75.83$1,040,539.26View SEC Filing  
4/6/2015Richard KuntzVPSell31,768$77.39$2,458,525.52View SEC Filing  
3/25/2015Gary Lee EllisCFOSell43,183$77.81$3,360,069.23View SEC Filing  
3/13/2015Omar IshrakCEOSell20,000$76.24$1,524,800.00View SEC Filing  
2/19/2015Christopher J OconnellEVPSell50,361$78.22$3,939,237.42View SEC Filing  
12/19/2014Richard KuntzVPSell12,855$74.54$958,211.70View SEC Filing  
12/2/2014Shirley A JacksonDirectorSell1,102$74.43$82,021.86View SEC Filing  
11/28/2014Christopher J OconnellEVPSell42,921$73.95$3,174,007.95View SEC Filing  
10/6/2014Christopher J OconnellEVPSell15,388$64.98$999,912.24View SEC Filing  
8/26/2014Christopher J OconnellEVPSell28,000$63.57$1,779,960.00View SEC Filing  
8/26/2014Shirley A JacksonDirectorSell2,769$63.66$176,274.54View SEC Filing  
4/17/2014Catherine SzymanVPSell29,420$58.79$1,729,601.8021,602View SEC Filing  
4/9/2014Richard KuntzVPSell2,512$60.98$153,181.76104,736View SEC Filing  
4/1/2014Gary Lee EllisCFOSell4,246$61.48$261,044.08174,955View SEC Filing  
3/28/2014Christopher OconnellEVPSell1,982$60.39$119,692.98120,652View SEC Filing  
3/20/2014Catherine SzymanVPSell14,979$59.57$892,299.0321,542View SEC Filing  
3/14/2014Omar IshrakCEOSell10,000$59.12$591,200.00607,192View SEC Filing  
3/10/2014Neil AyotteVPSell1,845$59.64$110,035.8010,782View SEC Filing  
12/4/2013Neil AyotteVPSell1,729$57.14$98,795.0610,850View SEC Filing  
9/13/2013Omar IshrakCEOSell10,000$53.58$535,800.00611,713View SEC Filing  
8/26/2013Catherine SzymanVPSell56,998$52.60$2,998,094.8021,217View SEC Filing  
8/22/2013H James DallasVPSell32,332$53.19$1,719,739.0859,141View SEC Filing  
8/21/2013H James DallasVPSell36,256$52.82$1,915,041.9291,473View SEC Filing  
8/21/2013Shirley JacksonDirectorSell8,033$52.84$424,463.7224,943View SEC Filing  
7/11/2013Christopher J OconnellEVPSell30,429$52.92$1,610,302.68View SEC Filing  
7/11/2013Gary Lee EllisCFOSell32,602$53.62$1,748,119.24View SEC Filing  
7/11/2013H James DallasVPSell69,889$53.72$3,754,437.08View SEC Filing  
7/1/2013H James DallasVPSell20,579$52.10$1,072,165.90View SEC Filing  
6/26/2013D Cameron FindlayVPSell75,042$52.20$3,917,192.40View SEC Filing  
6/19/2013H James DallasVPSell94,117$52.74$4,963,730.58View SEC Filing  
5/22/2013Richard H AndersonDirectorBuy4,800$52.32$251,136.00View SEC Filing  
5/10/2013Jack W SchulerDirectorSell34,230$48.24$1,651,255.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medtronic (NYSE MDT) News Headlines

Source:
DateHeadline
Newly Published Market Research Report Projects Neurotechnology Market Will Reach $13.3B by 2022Newly Published Market Research Report Projects Neurotechnology Market Will Reach $13.3B by 2022
globenewswire.com - April 23 at 9:00 AM
ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration AgreementARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement
finance.yahoo.com - April 23 at 9:00 AM
Head to Head Analysis: Medtronic (MDT) vs. The CompetitionHead to Head Analysis: Medtronic (MDT) vs. The Competition
www.americanbankingnews.com - April 23 at 5:16 AM
NSAV ANNOUNCES CORRECTIVE PRESS RELEASE FOR THE HEARTRESCUE CHINA PROGRAMNSAV ANNOUNCES CORRECTIVE PRESS RELEASE FOR THE HEARTRESCUE CHINA PROGRAM
globenewswire.com - April 20 at 5:27 PM
Former Medtronic executive James Dallas to speak at awards eventFormer Medtronic executive James Dallas to speak at awards event
www.bizjournals.com - April 20 at 8:32 AM
Medtronic Expands Focus on Interventional Oncology with Its US Launch of OptiSphere(TM) Embolization SpheresMedtronic Expands Focus on Interventional Oncology with Its US Launch of OptiSphere(TM) Embolization Spheres
globenewswire.com - April 17 at 5:31 PM
BRIEF-Medtronic Announces US Launch Of Optisphere Embolization SpheresBRIEF-Medtronic Announces US Launch Of Optisphere Embolization Spheres
www.reuters.com - April 17 at 5:31 PM
Medtronic (MDT) Cut to "Buy" at BidaskClubMedtronic (MDT) Cut to "Buy" at BidaskClub
www.americanbankingnews.com - April 16 at 8:06 PM
Medtronic plc. (MDT) Expected to Post Quarterly Sales of $7.97 BillionMedtronic plc. (MDT) Expected to Post Quarterly Sales of $7.97 Billion
www.americanbankingnews.com - April 16 at 2:49 AM
Medtronic plc. (MDT) Given Consensus Rating of "Buy" by AnalystsMedtronic plc. (MDT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - April 15 at 5:43 PM
Deutsche Bank Reiterates "$96.00" Price Target for Medtronic (MDT)Deutsche Bank Reiterates "$96.00" Price Target for Medtronic (MDT)
www.americanbankingnews.com - April 15 at 9:51 AM
$1.38 Earnings Per Share Expected for Medtronic plc. (MDT) This Quarter$1.38 Earnings Per Share Expected for Medtronic plc. (MDT) This Quarter
www.americanbankingnews.com - April 14 at 3:11 PM
Medtronics (MDT) Buy Rating Reaffirmed at Jefferies GroupMedtronic's (MDT) Buy Rating Reaffirmed at Jefferies Group
www.americanbankingnews.com - April 13 at 11:43 PM
Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done YetTandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet
finance.yahoo.com - April 13 at 5:25 PM
Abbott’s Latest Valuation Metrics in April 2018Abbott’s Latest Valuation Metrics in April 2018
finance.yahoo.com - April 11 at 8:42 AM
Medtronic (MDT) Upgraded at BidaskClubMedtronic (MDT) Upgraded at BidaskClub
www.americanbankingnews.com - April 10 at 7:17 PM
Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark ApprovalMedtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval
globenewswire.com - April 10 at 5:22 PM
Analysts’ Latest Recommendations and Target Prices for AbbottAnalysts’ Latest Recommendations and Target Prices for Abbott
finance.yahoo.com - April 10 at 8:22 AM
Sleep-apnea device maker Inspire Medical files to raise $86.2M in IPOSleep-apnea device maker Inspire Medical files to raise $86.2M in IPO
finance.yahoo.com - April 10 at 8:22 AM
Healthcare and biotech investor Sami Hamade diesHealthcare and biotech investor Sami Hamade dies
finance.yahoo.com - April 9 at 5:24 PM
Medtronic to Unveil Additional Clinical Data on HVAD® System at ISHLT 2018Medtronic to Unveil Additional Clinical Data on HVAD® System at ISHLT 2018
finance.yahoo.com - April 9 at 5:24 PM
Medtronic on go with study of renal denervation device; shares up 1%Medtronic on go with study of renal denervation device; shares up 1%
seekingalpha.com - April 9 at 12:22 PM
Medtronic (MDT) Receives "Buy" Rating from SunTrust BanksMedtronic (MDT) Receives "Buy" Rating from SunTrust Banks
www.americanbankingnews.com - April 8 at 4:51 PM
Critical Comparison: Medtronic (MDT) & The CompetitionCritical Comparison: Medtronic (MDT) & The Competition
www.americanbankingnews.com - April 6 at 11:27 PM
Varian Medical Systems: Expanding in Proton TherapyVarian Medical Systems: Expanding in Proton Therapy
finance.yahoo.com - April 6 at 8:11 AM
What’s behind Edwards Lifesciences’ Latest ValuationWhat’s behind Edwards Lifesciences’ Latest Valuation
finance.yahoo.com - April 6 at 8:11 AM
Global Electroencephalography (EEG) Devices Market 2018-2022 - Key Vendors are Cadwell Industries ...Global Electroencephalography (EEG) Devices Market 2018-2022 - Key Vendors are Cadwell Industries ...
www.prnewswire.com - April 5 at 5:27 PM
Medtronic (MDT) vs. Its Rivals Head to Head ReviewMedtronic (MDT) vs. Its Rivals Head to Head Review
www.americanbankingnews.com - April 5 at 9:43 AM
Critical Contrast: CONMED (CNMD) vs. Medtronic (MDT)Critical Contrast: CONMED (CNMD) vs. Medtronic (MDT)
www.americanbankingnews.com - April 5 at 5:25 AM
What’s Driving Boston Scientific Stock UpwardWhat’s Driving Boston Scientific Stock Upward
finance.yahoo.com - April 4 at 4:35 PM
Analysts Give Edwards Lifesciences Mostly ‘Buy’ RatingsAnalysts Give Edwards Lifesciences Mostly ‘Buy’ Ratings
finance.yahoo.com - April 4 at 8:34 AM
Analyzing Medtronic (MDT) & Its CompetitorsAnalyzing Medtronic (MDT) & Its Competitors
www.americanbankingnews.com - April 4 at 1:23 AM
Medtronic (MDT) & Its Rivals Head-To-Head ComparisonMedtronic (MDT) & Its Rivals Head-To-Head Comparison
www.americanbankingnews.com - April 3 at 9:20 PM
The Zacks Analyst Blog Highlights: United Technologies, Medtronic, Gilead, Hewlett Packard and Yum! BrandsThe Zacks Analyst Blog Highlights: United Technologies, Medtronic, Gilead, Hewlett Packard and Yum! Brands
finance.yahoo.com - April 3 at 5:22 PM
Medtronic (MDT) Lifted to "Buy" at Bank of AmericaMedtronic (MDT) Lifted to "Buy" at Bank of America
www.americanbankingnews.com - March 31 at 11:55 AM
Medtronic (MDT) Coverage Initiated at Evercore ISIMedtronic (MDT) Coverage Initiated at Evercore ISI
www.americanbankingnews.com - March 30 at 11:40 PM
$7.97 Billion in Sales Expected for Medtronic plc. (MDT) This Quarter$7.97 Billion in Sales Expected for Medtronic plc. (MDT) This Quarter
www.americanbankingnews.com - March 30 at 2:12 AM
Call Buying Options Activity in Medtronic (MDT) Targets Upside in Shares Into June -SusquehannaCall Buying Options Activity in Medtronic (MDT) Targets Upside in Shares Into June -Susquehanna
www.streetinsider.com - March 29 at 5:16 PM
Medtronic (MDT) PT Lowered to $90.00 at Morgan StanleyMedtronic (MDT) PT Lowered to $90.00 at Morgan Stanley
www.americanbankingnews.com - March 29 at 12:11 PM
 Brokerages Expect Medtronic plc. (MDT) Will Post Earnings of $1.38 Per Share Brokerages Expect Medtronic plc. (MDT) Will Post Earnings of $1.38 Per Share
www.americanbankingnews.com - March 28 at 5:22 PM
Trade War Fears Grip MedTech: 3 Stocks on the Line of FireTrade War Fears Grip MedTech: 3 Stocks on the Line of Fire
finance.yahoo.com - March 28 at 5:19 PM
BRIEF-Medtronic To Redeem About $1.2 Bln Of Medtronic Incs Senior NotesBRIEF-Medtronic To Redeem About $1.2 Bln Of Medtronic Inc's Senior Notes
www.reuters.com - March 24 at 5:34 PM
Should Value Investors Consider Medtronic (MDT) Stock Now?Should Value Investors Consider Medtronic (MDT) Stock Now?
finance.yahoo.com - March 23 at 6:08 PM
Q1 2019 Earnings Forecast for Medtronic plc. Issued By Leerink Swann (MDT)Q1 2019 Earnings Forecast for Medtronic plc. Issued By Leerink Swann (MDT)
www.americanbankingnews.com - March 23 at 12:48 PM
Medtronic PLC (MDT) Down -2.1% Since Earnings Report: Can It Rebound?Medtronic PLC (MDT) Down -2.1% Since Earnings Report: Can It Rebound?
www.zacks.com - March 22 at 5:34 PM
Leerink Swann Weighs in on Medtronic plc.s FY2018 Earnings (MDT)Leerink Swann Weighs in on Medtronic plc.'s FY2018 Earnings (MDT)
www.americanbankingnews.com - March 22 at 11:00 AM
What Could Boost Haemonetics’ Revenues in Future YearsWhat Could Boost Haemonetics’ Revenues in Future Years
finance.yahoo.com - March 22 at 8:27 AM
Medtronics (MDT) "Buy" Rating Reaffirmed at OppenheimerMedtronic's (MDT) "Buy" Rating Reaffirmed at Oppenheimer
www.americanbankingnews.com - March 21 at 7:16 PM
Covidien International Finance S.A. -- Moodys revises Medtronics rating outlook to stable from negative, A3 senior unsecured rating affirmedCovidien International Finance S.A. -- Moody's revises Medtronic's rating outlook to stable from negative, A3 senior unsecured rating affirmed
finance.yahoo.com - March 21 at 5:37 PM
HAE Is Well Placed to Compete in Plasma Collection in Fiscal 2018HAE Is Well Placed to Compete in Plasma Collection in Fiscal 2018
finance.yahoo.com - March 21 at 8:02 AM

SEC Filings

Medtronic (NYSE:MDT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medtronic (NYSE:MDT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medtronic (NYSE MDT) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.